Vimarsana
Biggest News Aggregation in the World

Page 10 - Addl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Addl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Addl Today - Breaking & Trending Today

Redrow Signs Building Safety Pledge, Sees £164 Mln Addl. Provision In FY22; Stock Down - Vimarsana News

Redrow Signs Building Safety Pledge, Sees £164 Mln Addl. Provision In FY22; Stock Down

LONDON (dpa-AFX) - Homebuilder Redrow Plc. (RDW.L) Wednesday said it has signed the U.K. Government's proposed building safety pledge regarding the remediation of life critical fire safety issues

Boeing Gets 20 Addl. Orders For 737-800 Boeing Converted Freighters From ASL Aviation - Vimarsana News

Boeing Gets 20 Addl. Orders For 737-800 Boeing Converted Freighters From ASL Aviation

CHICAGO (dpa-AFX) - The Boeing Co.(BA) said Thursday that it has received an order for up to 20 additional 737-800 Boeing Converted Freighters from ASL Aviation Holdings, an Irish aviation services

Wabtec Announces Addl Multi-year Order To Modernize Norfolk Southern 330 Locomotives - Vimarsana News

Wabtec Announces Addl Multi-year Order To Modernize Norfolk Southern 330 Locomotives

NORFOLK (dpa-AFX) - Wabtec Corp. (WAB) said that it has received an additional multi-year order from Norfolk Southern (NSC) to modernize 330 locomotives. The deal is part of Norfolk Southern's

Dingdong (Cayman) (NYSE:DDL) Shares Gap Up to $3.79 - Vimarsana News

Dingdong (Cayman) (NYSE:DDL) Shares Gap Up to $3.79

Dingdong (Cayman) Limited (NYSE:DDL – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $3.79, but opened at $3.91. Dingdong (Cayman) shares last traded at $3.91, with a volume of 6,697 shares traded. A number of equities analysts have recently issued reports on DDL shares. Zacks Investment […]

IDEAYA, Pfizer To Evaluate Darovasertib- Crizotinib Combination In MUM And Addl CMET-Driven Tumors - Vimarsana News

IDEAYA, Pfizer To Evaluate Darovasertib- Crizotinib Combination In MUM And Addl CMET-Driven Tumors

NEW YORK CITY (dpa-AFX) - IDEAYA Biosciences, Inc. (IDYA), a synthetic lethality focused precision medicine oncology company, announced Monday that it has entered into additional clinical trial